PetMed Express (NASDAQ:PETS) Releases Earnings Results, Misses Estimates By $0.06 EPS

PetMed Express (NASDAQ:PETS) issued its earnings results on Sunday. The company reported $0.34 EPS for the quarter, missing the Zacks’ consensus estimate of $0.40 by ($0.06), MarketWatch Earnings reports. The company had revenue of $71.70 million for the quarter, compared to analysts’ expectations of $74.04 million. PetMed Express had a return on equity of 22.79% and a net margin of 9.82%. The business’s revenue was down 3.5% compared to the same quarter last year. During the same period last year, the business posted $0.35 earnings per share.

PETS stock traded up $0.77 during trading on Tuesday, hitting $30.25. 713,639 shares of the company’s stock traded hands, compared to its average volume of 758,766. The firm has a market capitalization of $613.20 million, a P/E ratio of 19.65 and a beta of 0.70. The business has a fifty day simple moving average of $32.75 and a two-hundred day simple moving average of $32.72. PetMed Express has a 1 year low of $27.60 and a 1 year high of $57.00.

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, May 21st. Investors of record on Friday, May 14th will be issued a dividend of $0.30 per share. This represents a $1.20 annualized dividend and a yield of 3.97%. This is a positive change from PetMed Express’s previous quarterly dividend of $0.28. The ex-dividend date is Thursday, May 13th.

Separately, Sidoti raised shares of PetMed Express from a “neutral” rating to a “buy” rating in a report on Thursday, March 11th.

About PetMed Express

PetMed Express, Inc, together with its subsidiaries, doing business as 1-800-PetMeds, operates as a pet pharmacy in the United States. The company markets prescription and non-prescription pet medications, and other health products for dogs, cats, and horses. It offers non-prescription medications and supplies, such as flea and tick control products, bone and joint care products, vitamins, treats, nutritional supplements, hygiene products, and supplies; and prescription medications, including heartworm preventative, flea and tick preventative, arthritis, dermatitis, thyroid, diabetes, pain medications, heart/blood pressure, and other specialty medications, as well as generic substitutes.

Read More: What sectors are represented in the FTSE 100 index?

Earnings History for PetMed Express (NASDAQ:PETS)

Receive News & Ratings for PetMed Express Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for PetMed Express and related companies with MarketBeat.com's FREE daily email newsletter.